JP Morgan Chase’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,000
| Closed | -$3.44M | – | 7261 |
|
|
2021
Q3 | $3.44M | Buy |
+20,000
| New | +$2.62M | ﹤0.01% | 3339 |
|
|
2020
Q3 | – | Sell |
-44,000
| Closed | -$4.19M | – | 5939 |
|
|
2020
Q2 | $4.19M | Buy |
+44,000
| New | +$4.24M | ﹤0.01% | 2590 |
|
|
2019
Q3 | – | Sell |
-30,000
| Closed | -$1.23M | – | 6071 |
|
|
2019
Q2 | $1.23M | Sell |
30,000
-10,000
| -25% | -$414K | ﹤0.01% | 3718 |
|
|
2019
Q1 | $1.86M | Buy |
40,000
+10,000
| +33% | +$439K | ﹤0.01% | 3378 |
|
|
2018
Q4 | $1.31M | Buy |
+30,000
| New | +$1.5M | ﹤0.01% | 3575 |
|
|
2018
Q1 | – | Sell |
-40,000
| Closed | -$1.7M | – | 5721 |
|
|
2017
Q4 | $1.7M | Buy |
+40,000
| New | +$1.5M | ﹤0.01% | 3413 |
|
|
2015
Q4 | – | Sell |
-40,000
| Closed | -$996K | – | 4852 |
|
|
2015
Q3 | $996K | Buy |
+40,000
| New | +$1.2M | ﹤0.01% | 3104 |
|
JP Morgan Chase's XLRN Position: Q4 2021 in Review
JP Morgan Chase sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 113,485 shares — an estimated $19.5M sold.
JP Morgan Chase first reported a position in XLRN in Q4 2013 and held it in 31 quarters. The position peaked at $40.9M in Q4 2015. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- JP Morgan Chase reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- JP Morgan Chase sold 113,485 Acceleron Pharma shares in Q4 2021, an estimated $19.5M.
- JP Morgan Chase first reported a position in Acceleron Pharma in Q4 2013 and held it in 31 quarters.
- JP Morgan Chase's Acceleron Pharma position peaked at $40.9M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.